Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I.

Discovery immunology·2026
Same author

Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID.

Communications medicine·2026
Same author

Contrasting roles for IKK-regulated inflammatory signalling pathways for development and maintenance of type 1 and adaptive γδ T cells.

eLife·2026
Same author

T cell competition in multi-neoantigen cancer vaccines.

Nature reviews. Immunology·2026
Same author

Aberrant basal cell clonal dynamics shape early lung carcinogenesis.

Science (New York, N.Y.)·2025
Same author

Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation·2025

Related Experiment Video

Updated: May 18, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Increased HLA-E expression in white matter lesions in multiple sclerosis.

Pascal F Durrenberger1, Louise V Webb, Malcolm J W Sim

  • 1Department of Medicine, Section of Infectious Diseases and Immunity, Hammersmith Hospital, Imperial College, London, UK.

Immunology
|October 9, 2012
PubMed
Summary

Human Leukocyte Antigen-E (HLA-E) is upregulated in multiple sclerosis (MS) brain lesions, particularly in active inflammatory sites. This suggests HLA-E may play a role in the central nervous system damage seen in MS.

More Related Videos

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Related Experiment Videos

Last Updated: May 18, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Area of Science:

  • Neuroimmunology
  • Molecular Immunology
  • Central Nervous System Pathology

Background:

  • Multiple sclerosis (MS) involves complex central nervous system (CNS) damage with autoimmune components.
  • Both adaptive and innate immune cells contribute to MS pathogenesis.
  • Human Leukocyte Antigen-E (HLA-E) is a non-classical MHC class Ib molecule interacting with NKG2A receptors on immune cells.

Purpose of the Study:

  • To investigate the expression and localization of HLA-E in MS brain tissue.
  • To determine if HLA-E expression correlates with lesion activity and inflammation in MS.

Main Methods:

  • Quantitative immunohistochemistry and confocal microscopy were used to analyze HLA-E expression in MS brain tissue.
  • Comparison of HLA-E levels in active MS lesions, chronic lesions, and healthy control white matter.
  • Assessment of HLA-E co-localization with infiltrating CD8+ cells.

Main Results:

  • HLA-E expression is significantly increased in white matter lesions of MS patients compared to controls.
  • Elevated HLA-E protein is found in endothelial cells of active MS lesions.
  • Increased HLA-E levels correlate with higher inflammation scores and are associated with CD8+ T cells.

Conclusions:

  • HLA-E is upregulated in active MS brain lesions, suggesting a role in CNS pathogenesis.
  • The findings implicate HLA-E modulation in stressed tissue and a potential role for HLA-E-restricted regulatory CD8+ cells in MS.